pyrotinib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Shanghai Jiao Tong University School of Medicine (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadbreast cancer

I am/have/hadher2+ breast cancer

I am/have/hadprogesterone

I am/have/hadgene amplification

I am/have/hadinvasive breast cancer

I am/have/hadprogesterone receptor

I am/have/hadbreast cancer stage

I am/have/hadher2 gene amplification

I am/have/hadestrogen receptor

I am/have/hadestrogen

I am/have/hadadjuvant therapy

I am/have/hadimmunohistochemistry

I am/have/hadHER2

I am/have/haderbb2 gene amplification

I am/have/hadprimary tumor

I am/have/hadcarcinoma

I am/have/hadher2-positive breast cancer

I am/have/hadbreast carcinoma

I am/have/hadher2 positive breast cancer

I am/have/hadcancer

added new label for I am/have/had

more

I am looking for

I am looking forpyrotinib

I am looking fortrastuzumab

I am looking forprogesterone

I am looking forestrogen

I am looking forpertuzumab

I am looking forpaclitaxel

I am looking foremtansine

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Pyrotinib Trastuzumab Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

This study aims to evaluate the efficacy and safety of pyrotinib in combination with trastuzumab, pertuzumab and nab-paclitaxel as neoadjuvant therapy in early stage or locally advanced HER2-positive breast cancer.

HER2

erbb2 gene amplification

carcinoma

her2-positive breast cancer

invasive breast cancer

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.